Edenred Shares Drop 2.27% to €21.57 After Rebound, Shorts at 9.59%
Edenred shares fall 2.27% to €21.57 by midday, among the largest declines in the SBF 120. The movement follows a 4% rebound the previous day, which had allowed the stock to break through its resistance at €21.76. The consolidation occurs in an otherwise positive Parisian market, with the SBF 120 up 0.56% during the session.
Consolidation After Breaking Resistance the Previous Day
The stock falls back below the €21.76 threshold, a level crossed during a significant rise the previous day. The RSI at 69 indicates the exhaustion of the rebound that began in late April, nearing the overbought zone. Edenred is the second largest decline in the SBF 120 at mid-session, behind Nanobiotix, which fell by 7.22%. Despite this setback, the stock maintains a three-month gain of 21.11% and remains above its three moving averages. The price is 11.07% above the MM50 (€19.42) and 6% above the MM200 (€20.35), confirming the medium-term momentum. However, the performance over one year remains negative at -20.79%.
Persistent Selling Pressure and Discounted Valuation Relative to the Sector
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
According to reviewed statements, the cumulative net short positions reach 9.59% of the capital, supported by ten funds including Canada Pension Plan Investment Board (1.81%), Two Sigma Investments (1.39%), and Marshall Wace (1.22%). The level has decreased by 1.01 points over 30 days but remains high, indicating persistent selling pressure on the stock. The next important date on the financial calendar is the publication of the first half of 2026's revenue, expected on July 23, 2026.
SectorTickets restaurants›Services de traitement des transactions
Context
Period
Period: 3T 2025
Guidance from the release
Edenred confirme la solidité de son modèle économique et réaffirme ses objectifs 2025, visant au moins 10 % de croissance organique de l’EBITDA et un taux de conversion Free-cash-flow/EBITDA supérieur à 70 %.
Croissance organique accélérée au T3 2025 (+8,2 % chiffre d’affaires opérationnel) portée par toutes les lignes de métier, forte dynamique en Amérique latine et amélioration en Europe; Mobilité en croissance à deux chiffres; Solutions complémentaires en repli. Effets de change négatifs et impact réglementaire en Italie (plafonnement commissions) anticipés.
Risks mentioned
Impact négatif attendu de 60 millions d’euros d’EBITDA lié au plafonnement des commissions marchands en Italie
Effets de change défavorables (dépréciation des devises en Amérique latine, notamment réal brésilien et peso mexicain)
Environnement macroéconomique incertain pouvant affecter la consommation et la demande
Opportunities identified
Hausses des valeurs faciales des titres-restaurant dans plusieurs pays (ex. Belgique +25% à partir du 1er janvier 2026) soutenant la croissance organique
Partenariats stratégiques (Visa, Esso, grand distributeur de carburant) renforçant l’offre et l’accès au marché
Déploiement des solutions Beyond Food et Beyond Fuel et conquête du segment PME encore sous-pénétré
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.